Atossa Therapeutics, Inc. (NASDAQ:ATOS) Q4 2024 Earnings Call Transcript March 25, 2025
Atossa Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.06.
Operator: Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Joelle, and I will be your conference operator today. All participants will be in a listen-only mode. [Operator Instructions] A replay of this call will be...
